Subscribe
Home
Issues
Issue Archive
Latest Issue
Special Issues
Browse By Topic
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In the News
Press Releases
Submit an Article
Author Guidelines
About
About RPM
Mission Statement
Contact Us
Issues
2016
August 2016, Vol 4, No 4
Urology Practice Management - December 2015, Vol 4, No 6
Genomic Test Supports Treatment Decisions in Prostate Cancer
By
Phoebe Starr
Prostate Cancer
A genomic classifier is now available that can predict a low or high risk for metastasis in men with prostate cancer who have rising prostate-specific antigen (PSA) after a prostatectomy. The good news is that this test is reimbursable by Medicare.
Read More ›
New Prostate Cancer Biomarkers Can Predict Aggressive Disease in African Americans
By
Kristen Chanley
Prostate Cancer
It is well-known that African-American men have a higher incidence of prostate cancer and a greater mortality rate than American men of other races and ethnicities.
Read More ›
Your Patients Are Waiting for You Online
By
Mariana S-B Lamb, MS
Telemedicine
Healthcare is among the top economic and social problems across the globe in terms of patient access to care and affordability.
Read More ›
CMS Unveils Equity Plan to Improve Quality, Increase Access to Care
By
Rosemary Frei, MSc
Health Policy
The Centers for Medicare & Medicaid Services (CMS) Office of Minority Health has released a 19-page plan to address health equity gaps for underserved Medicare beneficiaries, improve their access to care, and measure the success of this undertaking.
Read More ›
Patient-Derived Tumor Xenografts May Help to Personalize Bladder Cancer Treatment
By
Laura Morgan
Bladder Cancer
In the era of personalized medicine, identifying patients with cancer who will benefit most from a specific treatment is the Holy Grail. Currently, there is no test to identify effective chemotherapy before administering treatment.
Read More ›
Bladder Cancer Tumor Staging Postchemotherapy Accurately Predicts Survival
By
Rosemary Frei, MSc
Bladder Cancer
It is valid to predict survival using tumor stage after neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC), said Peter Black, MD, Senior Research Scientist, Vancouver Prostate Centre, British Columbia, Canada.
Read More ›
African Americans Still Underrepresented in Urology
By
Ruth Cannon
Diversity in Urology
African Americans in urology are very slowly increasing in numbers and prominence, helped by networking and mentorship and through associations for African-American physicians, according to some senior African- American urologists.
Read More ›
New Mobile App Lets Men with LUTS Go with the Flow
By
Rosemary Frei, MSc
Urinary Tract Symptoms
Inventive Korean researchers are testing an app that plays the sound of running water to help men with lower urinary tract symptoms (LUTS) to “let go and let it flow.”
Read More ›
HIPAA Incident Response: A Team Approach to Protecting Patients’ Health Information
By
Angela E. Simmons
HIPAA Compliance
What does a Health Insurance Portability and Accountability Act (HIPAA)-related “incident response” mean to your organization and your oncology practice?
Read More ›
Life Insurance as a Charitable Gift
By
Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF
Financial Management
Philanthropic individuals can contribute a wide variety of assets to charity. In addition to the social good that comes with the contribution, there may also be a financial benefit to the donor through an income tax charitable deduction for the charitable gift.
Read More ›
December 2021, Vol 9, No 1
Read Now
Home
Issues
Issue Archive
Latest Issue
Special Issues
Browse By Topic
Web Exclusives
All Web Exclusives
FDA Approvals, News & Updates
In the News
Press Releases
Submit an Article
Author Guidelines
About
About RPM
Mission Statement
Contact Us